Analytical Similarity Assessment in Biosimilar Product Development

Author



Shein-Chung Chow, Ph.D, is currently an Associate Director at Office of



Biostatistics, Center for Drug Evaluation and Research, United States Food



and Drug Administration (FDA). Prior to joining FDA, Dr. Chow was a



Professor at Duke University School of Medicine, Durham, NC. He was



also a special government employee (SGE) appointed by the FDA as an



Advisory Committee member and statistical advisor to the FDA. Prior to



that, Dr. Chow also held various positions in the pharmaceutical industry



such as Vice President at Millennium, Cambridge, MA, Executive Director at



Covance, Princeton, NJ, and Director and Department Head at Bristol-Myers



Squibb, Plainsboro, NJ. Dr. Chow is the Editor-in-Chief of the Journal of



Biopharmaceutical Statistics and the Editor-in-Chief of the Biostatistics Book Series



at Chapman and Hall/CRC Press, Taylor & Francis Group. He was elected



Fellow of the American Statistical Association and an elected member of the



ISI (International Statistical Institute). Dr. Chow is the author or co-author of



over 300 methodology papers and 29 books including Designs and Analysis



of Bioavailability and Bioequivalence Studies, Sample Size Calculations in Clinical



Research, Adaptive Design Methods in Clinical Trials, Translational Medicine,



Design and Analysis of Clinical Trials, and Quantitative Methods for Traditional



Chinese Medicine Development.